|
FBXL5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
5.03000000540155E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
3.121200E-01 |
| Stage1-vs-Stage3 |
2.660200E-02 |
| Stage1-vs-Stage4 |
1.418240E-04 |
| Stage2-vs-Stage3 |
3.290000E-02 |
| Stage2-vs-Stage4 |
2.403800E-03 |
| Stage3-vs-Stage4 |
1.277820E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.63949999973678E-07 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
2.078000E-01 |
| Caucasian-vs-Asian |
2.393400E-01 |
| AfricanAmerican-vs-Asian |
1.284800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.44249065417534E-15 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
3.008600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
4.911900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.248400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.941800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.986600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.666000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.875000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.826800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.5046000524992E-09 |
| Classical-VS-Follicular |
1.416480E-03 |
| Classical-VS-Other |
7.605400E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
4.0127012823632E-11 |
| Tall-VS-Other |
1.013030E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
2.063800E-01 |
| Follicular-VS-Normal |
2.56130000542143E-08 |
| Other-VS-Normal |
3.8254999999987E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.44089209850063E-16 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
1.97491999999189E-05 |
|
|
